ET-1 receptor antagonists have been shown to be effective to treat VEGFR-TKI-associated hypertension in a pre-clinical study suggesting the involvement of ET-1 in VEGFR-TKI-related hypertension (101). Here, EDN1 is linked to hypertensive disorder.